A rapid a-synuclein seed assay of Parkinson’s disease CSFpanel shows high diagnostic accuracy

Assays that specifically measure a-synuclein seeding activity in
biological fluids could revolutionize the diagnosis of Parkinson’s disease. Recent
improvements in a-synuclein real-time quaking-induced conversion assays of
cerebrospinal fluid have dramatically reduced reaction times from 5-13 days
down to 1-2 days.    Click here for report